These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35879546)

  • 1. O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1.
    Zhu Q; Zhou H; Wu L; Lai Z; Geng D; Yang W; Zhang J; Fan Z; Qin W; Wang Y; Zhou R; Yi W
    Nat Chem Biol; 2022 Oct; 18(10):1087-1095. PubMed ID: 35879546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultradeep O-GlcNAc proteomics reveals widespread O-GlcNAcylation on tyrosine residues of proteins.
    Hou C; Deng J; Wu C; Zhang J; Byers S; Moremen KW; Pei H; Ma J
    Proc Natl Acad Sci U S A; 2024 Nov; 121(47):e2409501121. PubMed ID: 39531497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development.
    Tinsley SL; Chianis ERD; Shelley RA; Mall GK; Dhiman A; Baral G; Kothandaraman H; Thoma MC; English IA; Daniel CJ; Acosta LCS; Solorio L; Atallah Lanman N; Pasca di Magliano M; Narla G; Dykhuizen EC; Sears RC; Allen-Petersen BL
    Oncogene; 2024 Dec; 43(50):3673-3687. PubMed ID: 39443726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults.
    Love AMA; Edwards C; Cai RY; Gibbs V
    Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP1 Overexpression Enhances the Aerobic Glycolysis Process via Suppression of EGLN2 in Pancreatic Ductal Adenocarcinoma.
    Hu P; Dou R; Qi Z; Liu G; Su Y
    J Gene Med; 2024 Dec; 26(12):e70006. PubMed ID: 39647834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Field Theory of Executive Function: Identifying Early Neurocognitive Markers.
    McCraw A; Sullivan J; Lowery K; Eddings R; Heim HR; Buss AT
    Monogr Soc Res Child Dev; 2024 Dec; 89(3):7-109. PubMed ID: 39628288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAcylation of ribosome-associated proteins is concomitant with translational reprogramming during proteotoxic stress.
    Zeidan Q; Tian JL; Ma J; Eslami F; Hart GW
    J Biol Chem; 2024 Nov; 300(11):107877. PubMed ID: 39395807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plain language summary about a cell cycle-based, new surveillance mechanism against cancer.
    Qin A
    Future Oncol; 2024 Dec; 20(39):3209-3212. PubMed ID: 39324725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "I've Spent My Whole Life Striving to Be Normal": Internalized Stigma and Perceived Impact of Diagnosis in Autistic Adults.
    Huang Y; Trollor JN; Foley KR; Arnold SRC
    Autism Adulthood; 2023 Dec; 5(4):423-436. PubMed ID: 38116050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer.
    Singhal A; Styers HC; Rub J; Li Z; Torborg SR; Kim JY; Grbovic-Huezo O; Feng H; Tarcan ZC; Sahin Ozkan H; Hallin J; Basturk O; Yaeger R; Christensen JG; Betel D; Yan Y; Chio IIC; de Stanchina E; Tammela T
    Cancer Discov; 2024 Nov; 14(11):2122-2134. PubMed ID: 38975873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism.
    Wu X; Adame-Garcia SR; Koshizuka K; Vo PTT; Hoang TS; Sato K; Izumi H; Goto Y; Allevato MM; Wood KC; Lippman SM; Gutkind JS
    Cancer Prev Res (Phila); 2024 Dec; 17(12):571-583. PubMed ID: 39463147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of ROS signaling by TIGAR induces cancer-modulating responses in the tumor microenvironment.
    Cheung EC; Strathdee D; Stevenson D; Coomes J; Blyth K; Vousden KH
    Proc Natl Acad Sci U S A; 2024 Dec; 121(50):e2416076121. PubMed ID: 39636862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the urea cycle by CPS1 O-GlcNAcylation in response to dietary restriction and aging.
    Wu J; Liu J; Lapenta K; Desrouleaux R; Li MD; Yang X
    J Mol Cell Biol; 2022 Jul; 14(3):. PubMed ID: 35285892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSP70-mediated mitochondrial dynamics and autophagy represent a novel vulnerability in pancreatic cancer.
    Ferretti GDS; Quaas CE; Bertolini I; Zuccotti A; Saatci O; Kashatus JA; Sharmin S; Lu DY; Poli ANR; Quesnelle AF; Rodriguez-Blanco J; de Cubas AA; Hobbs GA; Liu Q; O'Bryan JP; Salvino JM; Kashatus DF; Sahin O; Barnoud T
    Cell Death Differ; 2024 Jul; 31(7):881-896. PubMed ID: 38802657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance evaluation of a CRISPR Cas9-based selective exponential amplification assay for the detection of KRAS mutations in plasma of patients with advanced pancreatic cancer.
    Shen Y; Zhang X; Zhang L; Zhang Z; Lyu B; Lai Q; Li Q; Zhang Y; Ying J; Song J
    J Clin Pathol; 2024 Nov; 77(12):853-860. PubMed ID: 37679033
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.